Zimulti Information

Zimulti (rimonabant, Acomplia )

Zimulti (rimonabant) is an anti-obesity drug. It was approved for marketing as Acomplia in the European Union in June 2006. Zimulti is not yet approved for use in the United States.

Is Zimulti for me ?

Zimulti is used complementary to diet and exercise to treat obese or overweight patients who suffer from Type 2 diabetes and abnormal levels of fat in the blood. Sanofi argues that Zimulti can also prevent the risk of cardiovascular disease.

Are there any side effects of Zimulti (rimonabant, Acomplia ) ?

• Side effects in the trial on Zimulti in obesity were vomiting and nausea, forcing about 19 percent of patients to leave the trial versus 13 percent of those who took placebo.
• Clinical studies found that 26 percent of people taking Zimulti reported psychiatric symptoms, including anxiety, insomnia, panic attacks as well as increases in aggression and agitation compared to patients given a placebo.
• Zimulti has also been shown to cause increased suicidal tendencies and other depressive symptoms.

How does Zimulti work ?

Zimulti is used complementary to diet and exercise to treat obese or overweight patients who suffer from Type 2 diabetes and abnormal levels of fat in the blood. It can also prevent the risk of cardiovascular disease.

Zimulti Dosage

The usual dose is one 20 mg tablet to be taken once daily in the morning before breakfast. Swallow the tablet whole.

Customer support

+1(210) 888-9089

What credit cards do you accept ?

We accept Visa, MasterCard, AmEx, Diners, e-check, and JCB cards.

Where do U ship Orders ?

We ship to Worldwide.